A case-control study involving interviews with 1,200 patients with esophageal cancer and 1,200 population-based controls has been initiated in Linxian, a county in North Central China with perhaps the world's highest mortality rates for this tumor. Here we describe the rationale, study methods, and results of a pilot study that established the feasibility of the investigation.